Shares of Aveo Pharmaceuticals (AVEO) slide 10.63% AH as the company says it "received a subpoena from the SEC requesting documents and information concerning tivozanib" on July 3. (
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.